Treatment of Tinea Corporis When Oral Antifungal Therapy Is Indicated

Clinical Scenario

Tinea corporis is a dermatophyte infection of the skin that often responds to topical therapy. In certain clinical situations, however, topical treatment alone is insufficient and systemic management is required.

When This Protocol Applies

Oral antifungal agents may be indicated when the disease is extensive, when topical treatment has already been tried and failed, or in other specific presentations where a systemic approach is warranted.

Treatment Approach

The approach involves oral antifungal agents. The specific selection, sequencing, and complete regimen details are available in the full structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

Tinea corporis, tinea cruris, and tinea pedis are generally responsive to topical creams such as terbinafine (Lamisil) and butenafine (Lotrimin), but oral antifungal agents may be indicated for extensive disease, failed topical treatment, immunocompromised patients, or severe moccasin-type tinea pedis.

View source ↗